 earli thrombolyt treatment reduc analges requir patient myocardi infarct durat amount analges patient myocardi infarct intraven recombin tissue-typ plasminogen activ rtpa placebo random double-blind trial infus rtpa mg /placebo onset symptom requir analges follow sixty-seven cent rtpa-treat patient analges treatment patient placebo group studi period patient rtpa group equival mg median valu intraven morphin mg placebo group conclus present studi earli thrombolysi intraven rtpa amount durat analges treatment patient myocardi infarct